See figures below. In 2012, in the us, there are expected to be about 65, 000 new cases of renal cancer and about 13, 500 deaths.
Yes early diagnosis. Yes if diagnosedearly and treated early bebre it spreads.
Sure. Early stage of renal cancer is curable with surgical resection. The earlier the stage of the cancer, the higher your chance to survive/ to be cured.
Renal cell ca. In general-- stage I kidney cancer-- a 5-year survival rate over 90 % stage 2 - a five-year survival rates ranging from 75 to 95 % stage 3 - ranges from ranges from 46 to 70 % the median survival for patients with stage IV disease is 16 to 20 months in contemporary studies -with 5 year survival less than 10%.
There's a mistake. Non-small-cell is a group of lung cancers, not renal (kidney) cancers. I am sorry that someone made a mistake and I hope this helps explain why you have had difficulty finding information. Good luck.
Yes. Screening for renal cancer is not done routinely on every body, like breast, or prostate cancer, unless there is strong suspicion for it, like blood in urine, abnormal cells, pain, feeling a mass very strong family history, or detecting mass it in a ct done for some thing else.
Depends on stage. Best answer will come from review of patient specifics with treating urologist.
Depends upon type, Size ; if cancer has spread, if so where i.E just locally, to lymph nodes, into blood vessels or distant metastases. Also prognosis depends upon cell type ; how aggessive. Rcc most common. Transitional cell cancer, if caught early has reasonable prognosis. Sarcomas have a poor prognosis. Cancer in cyst tends to havebetter prognosis. Wilms tumors in kids w favorable cell type have good chance 4cure.
Variable. There are many types of renal cancer, with different outcomes. As your are 37 years old, renal cell carcinoma may be the type you are most interested in. Although not common, some individuals with stage 4 renal cell carcinoma have had prolonged (many years) of good quality life after diagnosis. I would recommend discussion with an oncologist about options for treatment.